AnandRathi

Remus Pharmaceuticals Ltd Fundamental Analysis

Last Updated Date: 23 Oct 2026
₹880.60
-20.60 (-2.29%)

Remus Pharmaceuticals Ltd (Remus Pharma.) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹1,038 crore.

Remus Pharmaceuticals Ltd Overview

Market cap₹1,038 Crs
Volume2,800
Prev. Close₹901.20
Year range₹580.00 - ₹1,039.00
ISININE0O5T01011

Remus Pharmaceuticals Ltd Fundamentals

ROCE(TTM)10.19%
P/E Ratio (TTM)41.99
P/B Ratio3.19
Debt to Equity0.02
ROE7.59%
EPS (TTM)20.47
Dividend Yield0.06%
Book Value276.40
Profit Margin0.00%
Operating Margin0.00%

Remus Pharmaceuticals Ltd Historical Performance

1 Month Return-9.89%
6 Month Return37.17%
3 Year Return27.28%
3 Month Return21.76%
1 Year Return30.74%
5 Year Return-

Remus Pharmaceuticals Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research